194 related articles for article (PubMed ID: 21220711)
21. Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model.
Liu K; Zhang X; Cao G; Liu Y; Liu C; Sun H; Pang X
Int J Nanomedicine; 2016; 11():2587-99. PubMed ID: 27354791
[TBL] [Abstract][Full Text] [Related]
22. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
23. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT
Su H; Xu X; Yan C; Shi Y; Hu Y; Dong L; Ying S; Ying K; Zhang R
Respir Res; 2018 Dec; 19(1):254. PubMed ID: 30547791
[TBL] [Abstract][Full Text] [Related]
24. [Hepatocyte growth factor intervention on rats with pulmonary hypertension and effect of endothelial cell membrane microparticles].
Liu Z; Zhang R; Yang Y; Wang J; He Z; Chen J
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):433-6. PubMed ID: 25200043
[TBL] [Abstract][Full Text] [Related]
25. Safety, Tolerability, and Pharmacokinetics of NK-104-NP.
Nakano K; Matoba T; Koga JI; Kashihara Y; Fukae M; Ieiri I; Shiramoto M; Irie S; Kishimoto J; Todaka K; Egashira K
Int Heart J; 2018 Sep; 59(5):1015-1025. PubMed ID: 30158384
[TBL] [Abstract][Full Text] [Related]
26. Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study.
McMurtry MS; Bonnet S; Michelakis ED; Bonnet S; Haromy A; Archer SL
Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L933-40. PubMed ID: 17675370
[TBL] [Abstract][Full Text] [Related]
27. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
Chang H; Chang CY; Lee HJ; Chou CY; Chou TC
Phytomedicine; 2018 Dec; 51():205-213. PubMed ID: 30466619
[TBL] [Abstract][Full Text] [Related]
28. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
Jiang L; Zhou T; Liu H
Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545
[TBL] [Abstract][Full Text] [Related]
29. Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats.
Xie L; Lin P; Xie H; Xu C
Clin Exp Hypertens; 2010; 32(8):547-54. PubMed ID: 21091363
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Ito T; Okada T; Miyashita H; Nomoto T; Nonaka-Sarukawa M; Uchibori R; Maeda Y; Urabe M; Mizukami H; Kume A; Takahashi M; Ikeda U; Shimada K; Ozawa K
Circ Res; 2007 Sep; 101(7):734-41. PubMed ID: 17673672
[TBL] [Abstract][Full Text] [Related]
31. Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension.
Ishihara T; Hayashi E; Yamamoto S; Kobayashi C; Tamura Y; Sawazaki R; Tamura F; Tahara K; Kasahara T; Ishihara T; Takenaga M; Fukuda K; Mizushima T
J Control Release; 2015 Jan; 197():97-104. PubMed ID: 25449809
[TBL] [Abstract][Full Text] [Related]
32. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
[TBL] [Abstract][Full Text] [Related]
33. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
Grobs Y; Awada C; Lemay SE; Romanet C; Bourgeois A; Toro V; Nadeau V; Shimauchi K; Orcholski M; Breuils-Bonnet S; Tremblay E; Provencher S; Paulin R; Boucherat O; Bonnet S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805714
[TBL] [Abstract][Full Text] [Related]
34. Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension.
Zhang LL; Lu J; Li MT; Wang Q; Zeng XF
Int J Rheum Dis; 2016 Feb; 19(2):192-8. PubMed ID: 24612527
[TBL] [Abstract][Full Text] [Related]
35. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
Matsuo S; Saiki Y; Adachi O; Kawamoto S; Fukushige S; Horii A; Saiki Y
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):902-9. PubMed ID: 25454916
[TBL] [Abstract][Full Text] [Related]
36. Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats.
Dumitrascu R; Kulcke C; Königshoff M; Kouri F; Yang X; Morrell N; Ghofrani HA; Weissmann N; Reiter R; Seeger W; Grimminger F; Eickelberg O; Schermuly RT; Pullamsetti SS
Eur Respir J; 2011 May; 37(5):1104-18. PubMed ID: 20947677
[TBL] [Abstract][Full Text] [Related]
37. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
Zhao YD; Courtman DW; Deng Y; Kugathasan L; Zhang Q; Stewart DJ
Circ Res; 2005 Mar; 96(4):442-50. PubMed ID: 15692087
[TBL] [Abstract][Full Text] [Related]
38. The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
Fan YF; Zhang R; Jiang X; Wen L; Wu DC; Liu D; Yuan P; Wang YL; Jing ZC
Cardiovasc Res; 2013 Aug; 99(3):395-403. PubMed ID: 23650288
[TBL] [Abstract][Full Text] [Related]
39. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats.
Wang Q; Zuo XR; Wang YY; Xie WP; Wang H; Zhang M
Vascul Pharmacol; 2013 Jan; 58(1-2):71-7. PubMed ID: 22846229
[TBL] [Abstract][Full Text] [Related]
40. Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension.
Segura-Ibarra V; Amione-Guerra J; Cruz-Solbes AS; Cara FE; Iruegas-Nunez DA; Wu S; Youker KA; Bhimaraj A; Torre-Amione G; Ferrari M; Karmouty-Quintana H; Guha A; Blanco E
Int J Pharm; 2017 May; 524(1-2):257-267. PubMed ID: 28359821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
